Recombinant
RabMAb

Recombinant Anti-Ephrin B2 antibody [EPR10072(B)] (ab150411)

Rabbit recombinant monoclonal Ephrin B2 antibody [EPR10072(B)]. Validated in WB, ICC/IF and tested in Mouse, Rat, Human. Cited in 6 publication(s). Independently reviewed in 3 review(s).

Publishing research using ab150411? Please let us know so that we can cite the reference in this datasheet.

ab150411 has been referenced in 6 publications.

  • Cao C  et al. Bidirectional juxtacrine ephrinB2/Ephs signaling promotes angiogenesis of ECs and maintains self-renewal of MSCs. Biomaterials 172:1-13 (2018). WB . PubMed: 29709731
  • Ge YW  et al. Titanium particle-mediated osteoclastogenesis may be attenuated via bidirectional ephrin-B2/eph-B4 signaling in vitro. Int J Mol Med 42:2031-2041 (2018). PubMed: 30015911
  • Jamshidi-Parsian A  et al. Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma. Exp Cell Res 372:16-24 (2018). PubMed: 30205087
  • Li M  et al. Porphyromonas gingivalis lipopolysaccharide regulates ephrin/Eph signalling in human periodontal ligament fibroblasts. J Periodontal Res 52:913-921 (2017). WB . PubMed: 28590061
  • Wu S  et al. MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients. EBioMedicine 12:133-142 (2016). WB ; Human . PubMed: 27650867
  • Chen II  et al. EphrinB2 regulates the emergence of a hemogenic endothelium from the aorta. Sci Rep 6:27195 (2016). ICC/IF ; Mouse . PubMed: 27250641

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
For licensing inquiries, please contact partnerships@abcam.com

Sign up